Logo

Asterand

MolecularMD, Asterand Bioscience Form Biomarker Alliance

The companies will work together to create an end-to-end workflow for biomarker and drug target validation, and assay development.

Asterand Awarded $6.5M Contract to Provide Tumor Samples, Data to NIH

The company will provide oncology specimens and associated clinical data to the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium.

5AM to Develop Biobanking, Data-Sharing Software for Asterand
Premium

5AM Solutions will develop software that will allow Asterand to electronically link multiple biorepositories and identify, annotate, and distribute biospecimen data internally and with collaborators.

Asterand Lands $5.4M NCI Contract

The contract to supply biospecimens for the Cancer Genome Atlas project could reach a total value of $24 million.

Asterand Subsidiary to Screen Amylin Library

BioSeek will apply its BioMap predictive human disease models to screen Amylin's library.
Breaking News
The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.